This educational activity is specifically designed for hematologists/oncologists, internists, nurses, pharmacists, and other healthcare professionals with an interest and/or involvement in hematologic malignancies. Objectives After successful completion of this course, attendees should be able to:
Discuss the most clinically relevant data presented at the 51st Annual Hematology Meeting
Analyze emerging data on multiple hematologic malignancies and benign abnormalities in order to improve patient outcomes
Explain the limitations and benefits of new and emerging therapies for the treatment of patients with benign and malignant hematologic conditions
Incorporate emerging data into the clinical management of patients with benign and malignant hematologic conditions
Discuss ways in which current clinical practice should be modified based on the latest advances in hematology
Past Events
Hematology San Francisco 2010: Advances in Science, Emerging Data and Novel Therapeutics - Highlights from the 51st Annual Hematology Meeting - 30 Jan 2010, Westin San Francisco Market Street, California, United States (2680)
Hematology San Francisco : Advances in Science, Emerging Data and Novel Therapeutics - Highlights from the Annual Hematology Meeting 2026
Important
Please, check "Hematology San Francisco : Advances in Science, Emerging Data and Novel Therapeutics - Highlights from the Annual Hematology Meeting" official website for possible changes, before making any traveling arrangements
